medroxyprogesterone acetate has been researched along with Cervicitis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gursahaney, PR; Hillier, SL; Meyn, LA; Sweet, RL; Wiesenfeld, HC | 1 |
| Baeten, JM; Chohan, V; Hassan, W; Kreiss, J; Lavreys, L; Mandaliya, K; McClelland, RS; Ndinya-Achola, J; Overbaugh, J | 1 |
| Denny, L; Kuhn, L; Pollack, AE; Wright, TC | 1 |
3 other study(ies) available for medroxyprogesterone acetate and Cervicitis
| Article | Year |
|---|---|
Combined hormonal contraception may be protective against Neisseria gonorrhoeae infection.
Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Hormonal; Female; Gonorrhea; Humans; Interviews as Topic; Longitudinal Studies; Male; Medroxyprogesterone Acetate; Neisseria gonorrhoeae; Sexual Behavior; Treatment Outcome; Urethritis; Uterine Cervicitis; Young Adult | 2010 |
Hormonal contraception and risk of cervical infections among HIV-1-seropositive Kenyan women.
Topics: Adult; Chlamydia Infections; Contraceptives, Oral, Hormonal; Developing Countries; Female; Follow-Up Studies; HIV Seropositivity; HIV-1; Humans; Injections, Intravenous; Kenya; Medroxyprogesterone Acetate; Proportional Hazards Models; Prospective Studies; Risk; Sex Work; Sexually Transmitted Diseases; Uterine Cervicitis | 2004 |
Prevalence of visible disruption of cervical epithelium and cervical ectopy in African women using Depo-Provera.
Topics: Adult; Aged; Aging; Atrophy; Cervix Uteri; Contraceptive Agents, Female; Epithelium; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Odds Ratio; Parity; South Africa; Ulcer; Uterine Cervical Diseases; Uterine Cervicitis | 1999 |